Valiant Organics Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹304 Cr +93.6% YoYSee revenue, profit and what management said. You are viewing Q2 FY25.
VO

Valiant Organics Ltd

Q2 FY25Chemicals & Petrochemicals

Valiant Organics Q2 FY25 earnings call: Revenue & Margins

Q2 FY25 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹160Cr
−21.2% YoY
−4.8% QoQ
Net profit
−₹12Cr
Q2 FY24: ₹5 Cr
Margin
0.5%
−7.5 pp YoY
−8.5 pp QoQ

Based on Valiant Organics Ltd's Q2 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹411
Market cap₹1.2K Cr
P/E23.7

The short version

Q2-FY25 Revenue from Operations: - Consolidated: INR 1,602 Mn (down 21.1% YoY from INR 2,031 Mn in Q2-FY24) - Standalone: INR 1,602 Mn (down 12.2% YoY from INR 1,825 Mn in Q2-FY24) - Sales Volume: - Overall sales volume declined by 6% in Q2-FY25 (Page 10) - Specific chemistry volume trends (in metric tons) for Q2-FY25 vs Q2-FY24: - Chlorination: 730 MT vs 894 MT - Hydrogenation: 479 MT vs 660 MT - Ammonolysis: 118 MT vs 136 MT - Others: 221 MT vs 348 MT - Outlook: - Q2-FY25 Consolidated Financials (Page 9 & 12): - EBITDA: INR 24 Mn, down 84.5% YoY from INR 155 Mn - Operating EBITDA Margin: 1.5%, down 613 bps YoY from 7.63% - Profit After Tax (PAT): INR (125) Mn, compared to PAT of INR 47 Mn YoY (loss vs profit) - PAT Margin: (7.80)%, down significantly from 2.31% - Q2-FY25 Standalone Financials (Page 14): - EBITDA: INR 23 Mn, down 86.7% YoY from INR 173 Mn - Operating EBITDA Margin: 1.44%, down 804 bps YoY from 9.48% - PAT: INR (112) Mn, down from INR 39 Mn YoY (loss vs profit) - PAT Margin: (6.99)%, down from 2.14% - Explicit Margin Outlook:

From Valiant Organics Ltd's Q2 FY25 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q2-FY25 Revenue from Operations:
  • Consolidated: INR 1,602 Mn (down 21.1% YoY from INR 2,031 Mn in Q2-FY24)
  • Standalone: INR 1,602 Mn (down 12.2% YoY from INR 1,825 Mn in Q2-FY24)
  • Sales Volume:
  • Overall sales volume declined by 6% in Q2-FY25 (Page 10)
  • Specific chemistry volume trends (in metric tons) for Q2-FY25 vs Q2-FY24:
  • Chlorination: 730 MT vs 894 MT
  • Hydrogenation: 479 MT vs 660 MT
  • Ammonolysis: 118 MT vs 136 MT
  • Others: 221 MT vs 348 MT

2 more points from Valiant Organics Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

See what Valiant Organics Ltd said on capital expenditure plans — free account, 30 seconds.

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Valiant Organics Ltd said on order book & pipeline — free account, 30 seconds.

Valiant Organics Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Valiant Organics Ltd Q2 FY25 results — key figures

Valiant Organics Ltd Q2 FY25 reported results vs Q2 FY24, ₹ crore
₹ CrQ2 FY25Q2 FY24YoYQ1 FY25QoQ
Revenue160203-21.2%168-4.8%
Operating profit (EBITDA)115-93.3%16-93.7%
Operating margin0.5%8%-7.5 pp9%-8.5 pp
Profit before tax-146-333.3%2-800%
Net profit (PAT)-125-340%-1—
EPS (₹)-4.631.58-393%-0.22—

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹304 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Himadri Special (Q2 FY25)

    1,135.21 Cr, up 13.01% YoY (Page 45) . Key concall takeaways from Himadri Speciality Chemical Ltd's Q2 FY25 earnings call — and how it ranks against sector…

  • Vidhi Specialty (Q2 FY25)

    Year-on-Year (Y-o-Y) growth: 13.9% (Page 8) . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q2 FY25 earnings call — and how it ranks…

  • Chemcon Speciality Chemicals (Q2 FY25)

    30% YoY). Key concall takeaways from Chemcon Speciality Chemicals Ltd's Q2 FY25 earnings call — and how it ranks against sector peers.

  • Excel Industries (Q2 FY25)

    Q2 FY25 standalone revenue from operations: ₹269 crore, up 1.51% QoQ from Q1 FY25 (₹265 crore). Key concall takeaways from Excel Industries Ltd's Q2 FY25…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Valiant Organics Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Valiant Organics Ltd Q2 FY25 results?

Q2-FY25 Revenue from Operations: - Consolidated: INR 1,602 Mn (down 21.1% YoY from INR 2,031 Mn in Q2-FY24) - Standalone: INR 1,602 Mn (down 12.2% YoY from INR 1,825 Mn in Q2-FY24) - Sales Volume: - Overall sales volume declined by 6% in Q2-FY25 (Page 10) - Specific chemistry volume trends (in metric tons) for Q2-FY25 vs Q2-FY24: - Chlorination: 730 MT vs 894 MT - Hydrogenation: 479 MT vs 660 MT - Ammonolysis: 118 MT vs 136 MT - Others: 221 MT vs 348 MT - Outlook: - Q2-FY25 Consolidated Financials (Page 9 & 12): - EBITDA: INR 24 Mn, down 84.5% YoY from INR 155 Mn - Operating EBITDA Margin: 1.5%, down 613 bps YoY from 7.63% - Profit After Tax (PAT): INR (125) Mn, compared to PAT of INR 47 Mn YoY (loss vs profit) - PAT Margin: (7.80)%, down significantly from 2.31% - Q2-FY25 Standalone Financials (Page 14): - EBITDA: INR 23 Mn, down 86.7% YoY from INR 173 Mn - Operating EBITDA Margin: 1.44%, down 804 bps YoY from 9.48% - PAT: INR (112) Mn, down from INR 39 Mn YoY (loss vs profit) - PAT Margin: (6.99)%, down from 2.14% - Explicit Margin Outlook:

What is Valiant Organics Ltd share price analysis?

Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.

Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.